IP Library Granted Patent US 8,647,604
Granted Patent B2
US 8,647,604 · App. 11/627,273 · Granted Feb 11, 2014

Lanthanide rich nanoparticles, and their investigative uses in MRI and related technologies

Inventors: Franciscus C. J. M. VanVeggel (British Columbia, CA); Robert Scott Prosser (Ontario, CA); Cunhai Dong (British Columbia, CA)
Assignee: UVic Industry Partnerships Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,647,604
App. No.
11/627,273
Granted
Feb 11, 2014
Kind
B2
Abstract

An aqueous soluble, lanthanide rich nanoparticle for investigative use, such as NMR, MRI, CT, PET, and GdNCT is provided. The nanoparticle is synthesized from a mixture comprising lanthanide ions and coated with a suitably selected organic ligand such that the resultant nanoparticle is soluble in aqueous solutions. A method of collecting nuclear magnetic resonance information on a sample or a subject is also provided.

Claims (36)

1. An aqueous-soluble, lanthanide-rich nanoparticle composite, comprising:

an inorganic, paramagnetic core consisting of at least one lanthanide ion selected from ions of Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, La, Lu, Y, and combinations thereof, and at least one anion selected from a halide, a phosphate, and a vanadate;

at least one aqueous-soluble, organic ligand selected from citrate, biotin, amino acids, H 3 N + CH 2 CH 2 OPO 3 2− , and combinations thereof, wherein the at least one aqueous-soluble, organic ligand is bound to the inorganic, paramagnetic core; and

at least one surface-modifying reagent that has been reacted with the at least one aqueous-soluble, organic ligand to form a surface-modifying reagent-aqueous soluble organic ligand reaction product.

2. The nanoparticle of claim 1 wherein said inorganic, paramagnetic core consists of at least two lanthanide ions.

3. The nanoparticle of claim 2 wherein said at least two lanthanide ions are Gd 3+ and La 3+ .

4. The nanoparticle of claim 3 wherein said inorganic, paramagnetic core comprises gadolinium fluoride and lanthanum fluoride.

5. The nanoparticle of claim 4 wherein said inorganic, paramagnetic core comprises at least 50% gadolinium fluoride.

6. The nanoparticle of claim 5 wherein said inorganic, paramagnetic core comprises at least 80% gadolinium fluoride.

7. The nanoparticle composite of claim 1 wherein said at least one aqueous-soluble, organic ligand is either citrate or H 3 N + CH 2 CH 2 OPO 3 2− .

8. The nanoparticle of claim 7 wherein said inorganic, paramagnetic core consists of gadolinium fluoride and lanthanum fluoride.

9. The nanoparticle composite of claim 1 wherein the at least one lanthanide ion is selected from ions of Eu, Gd, Ho, and Er.

10. The nanoparticle composite of claim 9 wherein said at least one lanthanide ion is a gadolinium ion.

11. The nanoparticle composite of claim 10 wherein said at least one lanthanide ion is provided as gadolinium fluoride.

12. The nanoparticle composite of claim 11 wherein said at least one aqueous-soluble, organic ligand is citrate or H 3 N + CH 2 CH 2 OPO 3 2− .

13. The nanoparticle composite of claim 7 wherein said nanoparticle composite ranges in size from about 10 nm to about 150 nm in diameter.

14. The nanoparticle composite of claim 13 wherein said nanoparticle composite ranges in size from about 10 nm to about 20 nm.

15. The nanoparticle of claim 7 wherein said at least one aqueous-soluble, organic ligand is citrate.

16. The nanoparticle composite of claim 15 wherein said nanoparticle composite ranges in size from about 5 nm to about 10 nm.

17. The nanoparticle composite of claim 1 wherein said nanoparticle composite is a core shell nanoparticle.

18. The core shell nanoparticles of claim 17 wherein said nanoparticles consists of GdF 3 :Eu(5%)-LaF 3 or LaF 3 —Gd:Eu(5%).

19. The nanoparticle composite of claim 1 wherein said nanoparticle composite is a core nanoparticle.

20. An aqueous-soluble, lanthanide-rich nanoparticle composite, comprising:

an inorganic, paramagnetic core consisting of at least one lanthanide ion selected from ions of Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, La, Lu, Y, and combinations thereof, and at least one anion selected from a halide, a phosphate, and a vanadate;

at least one H 3 N + CH 2 CH 2 OPO 3 2− ligand, wherein the at least one H 3 N + CH 2 CH 2 OPO 3 2− ligand is bound to the inorganic, paramagnetic core; and

at least one surface-modifying reagent selected from an activated ester, a polyethylene glycol, a peptide, an antibody, and combinations thereof, wherein the at least one surface- modifying reagent is bound to the at least one H 3 N + CH 2 CH 2 OPO 3 2− ligand through an amine of the H 3 N + CH 2 CH 2 OPO 3 2− ligand.

21. An aqueous-soluble, lanthanide-rich nanoparticle composite, consisting of:

an inorganic, paramagnetic core consisting of at least one lanthanide ion selected from ions of Eu, Gd, Dy, Ho, Er, La, Lu, Y, and combinations thereof, and at least one anion selected from a halide, a phosphate, and a vanadate;

at least one citrate ligand bound to the inorganic, paramagnetic core; and

at least one antibody that has been reacted with the at least one citrate ligand to form an antibody-citrate ligand reaction product useful for targeting the nanoparticle for a desired NMR, MRI, CT, PET, or NCT application.

22. The nanoparticle composite of claim 1 wherein the at least one surface-modifying reagent is selected from a reagent capable of detecting a target, a non- biological polymer, and combinations thereof.

23. The nanoparticle composite of claim 1 wherein the at least one surface-modifying reagent is selected from an activated ester, a polyethylene glycol, a peptide, an antibody, and any combinations thereof.

24. An aqueous-soluble, lanthanide-rich nanoparticle composite, comprising:

GdF 3 core;

at least one citrate ligand bound to the GdF 3 core; and

at least one antibody that has been reacted with the at least one citrate ligand to form an antibody-citrate ligand reaction product useful for targeting the nanoparticle for a desired NMR, MRI, CT, PET, or NCT application.

Assignments (2)
CHANGE OF NAME Recorded Sep 24, 2013
From: UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION
To: UVIC INDUSTRY PARTNERSHIPS INC.
Reel/Frame 031271/0970 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2007
From: VAN VEGGEL, FRANCISCUS C.J.M.; PROSSER, ROBERT S.; DONG, CUNHAI
To: UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION
Reel/Frame 019404/0500 →
Continuity (2)
Provisional Application 60762464 · Jan 25, 2006
Related Publication 20070218009A1 · Sep 20, 2007